PPT-Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors

Type 1 Diabetes Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors IntroductionOverview Intensive Therapy Reduces Diabetes Complications Rates Variability in TimeAction Profile of Basal Insulins. Levin, Jacqueline . Pistorello. , . Steven C. Hayes, John Seeley, . Crissa. Levin, Kristy . Dalrymple. , Brandon . Gaudiano. & . Jack . Haeger. Using adjunctive web/mobile ACT technologies to augment clinical practice. Roland Halil, . BScPharm, ACPR, PharmD. Clinical Pharmacist, Bruyere Academic Family Health Team. Assistant Professor, Dept of Family Medicine, U of Ottawa. July 2016. Objectives. List the classes of oral antihyperglycemic agents and understand their place in therapy.. Anne Daly, MS, RDN, BC-ADM, CDE. Southern Illinois . Univ. School of Medicine. Center for Family & Community Medicine. OBJECTIVES OF TALK. To review the goals of medical nutrition therapy (MNT), evidence for effectiveness & key MNT messages for PWD. Kelly Green Boesen, Pharm D, BCPS, CDE. Type 1 DM Treatment. Insulin!. Best results is to mimic normal physiology as close as possible. Long acting insulin, meal-time coverage with rapid acting insulin. Add on to insulin. EFFICACY AND TOLERABILITY. OF GLP-1 RECEPTOR AGONISTS. AND DPP-4 INHIBITORS AS ADDON THERAPY TO INSULIN . Complementing Insulin Therapy to Achieve Glycemic. Control. Anthony H. Barnett . Diabetes Mellitus: Overview of the Disease and Its Treatment. Diabetes mellitus . Greek word for “fountain”. Latin word for “honey”. Disorder of carbohydrate metabolism. Deficiency of insulin. SGLT Inhibitors. Program Overview. Glycemic Control in T1DM. Risks Associated With T1DM. Limitations of Insulin Therapy for T1DM. Noninsulin Therapy for T1DM: Pramlintide. T2DM Therapies for T1DM: Metformin. Rose M. Flinchum, MSEd., MS, CNS, RN, ACNS-BC, BC-ADM, CDE. Inpatient Diabetes CNS / Certified Diabetes Educator. Outpatient DSMES Quality Coordinator. Diabetes in our Practices. 2015 Statistics. 30.3 million Americans; 9.4% of the population. endophthalmitis. after intraocular procedure. Carol H Kim, Monica F Chen, Anne L Coleman. Issue 11, 2015. A presentation to:. Meeting name. Date. Table of Contents. 01. Background. 02. Types. of studies. Dr. . . Ghadiri. , MD. Assistance professor of endocrinology. Shahid. . Sadoughi. . University of Medical Sciences . 2. The importance of glycemic control in minimizing complications related to diabetes has been well established in type 1 diabetes . Definition. Type 1 Diabetes. : This refers to a genetically based condition in which the cells in the pancreas that normally produce a hormone called “Insulin” stop functioning. This often appears in childhood or early adolescence. The only treatment for Type 1 Diabetes is insulin replacement (by pump or injection). Without adequate supplementary insulin, blood sugar levels dramatically increase and glucose “spills over” into the urine.. Type 1 Diabetes: Before and After Insulin. 1. . The Case for Serendipity. Available at: http://www.mc.vanderbilt.edu/lens/article/?id=221&pg=999. Accessed April 6, 2010.. 2. . Westman. et al. . Perspectives in Biology and Medicine. What Follows Metformin? . James R. Gavin III, MD, PhD. CEO & Chief Medical Officer, Healing Our Village, Inc.. Clinical Professor of Medicine. Emory University, School of Medicine. Atlanta, Georgia USA. Disease . By . . Jean . Molinary. , . DO. Screening for Diabetes . in . Adults. ADA: Risk based, or starting at the age of 45, then every . 3 years . if normal. Diabetes is Target-oriented. :. Macrovascular complications: higher with DM.